Dr. Florian Lordick, MD, PhD - University of Leipzig - Professor

Dr. Florian Lordick

MD, PhD

University of Leipzig

Professor

Leipzig, Saxony | Germany

Main Specialties: Hematology & Oncology

Additional Specialties: Hematology and Oncology

Dr. Florian Lordick, MD, PhD - University of Leipzig - Professor

Dr. Florian Lordick

MD, PhD

Introduction

Primary Affiliation: University of Leipzig - Leipzig, Saxony , Germany

Specialties:

Additional Specialties:


View Dr. Florian Lordick’s Resume / CV

Publications

100Publications

4846Reads

105Profile Views

2910PubMed Central Citations

Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.

Gastric Cancer 2015 Apr 11;18(2):314-25. Epub 2014 Apr 11.

Department of Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-014-0367-xDOI Listing
April 2015
50 Reads
4 Citations
3.720 Impact Factor

Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.

Gastric Cancer 2014 1;17(3):478-88. Epub 2013 Sep 1.

Department of Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-013-0296-0DOI Listing
February 2015
25 Reads
5 Citations
3.720 Impact Factor

Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesis.

Authors:
Florian Lordick

Nat Rev Clin Oncol 2015 Jan 18;12(1):7-8. Epub 2014 Nov 18.

University Cancer Centre Leipzig (UCCL), University Hospital Leipzig, Liebigstrasse 20, D-04103 Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.195DOI Listing
January 2015
53 Reads
2 Citations
14.180 Impact Factor

Effect of a structured psycho-oncological screening and treatment model on mental health in cancer patients (STEPPED CARE): study protocol for a cluster randomized controlled trial.

Trials 2014 Dec 10;15:482. Epub 2014 Dec 10.

Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), Division of Epidemiology and Health Services Research, University Medical Center Mainz, Obere Zahlbacher Straße 69, 55131 Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-15-482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295289PMC
December 2014
158 Reads
2.120 Impact Factor

Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution.

Strahlenther Onkol 2014 Nov;190(12):1133-40

Department of Radiation Oncology, Marien Hospital Herne and Sankt Josef Hospital Bochum, Ruhr-Universität Bochum, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-014-0711-4DOI Listing
November 2014
66 Reads
4 Citations
2.914 Impact Factor

Rectal cancer with synchronous liver metastases: leave it all in? When (not) to resect the primary?

Authors:
Florian Lordick

Recent Results Cancer Res 2014 ;203:231-41

University Cancer Center Leipzig, University Clinic Leipzig, Liebigstr. 20, 04103, Leipzig, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-08060-4_16DOI Listing
November 2014
6 Reads

Proteomic and metabolic prediction of response to therapy in gastric cancer.

World J Gastroenterol 2014 Oct;20(38):13648-57

Michaela Aichler, Research Unit Analytical Pathology - Institute of Pathology, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i38.13648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194549PMC
October 2014
60 Reads
4 Citations
2.370 Impact Factor

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond.

Cancer Lett 2014 Aug 3;351(1):30-40. Epub 2014 Jun 3.

University Cancer Center Leipzig, University Clinic Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2014.05.019DOI Listing
August 2014
49 Reads
18 Citations
5.621 Impact Factor

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.

Oncotarget 2014 Aug;5(16):6620-32

Research Unit Analytical Pathology- Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstraße 1, Neuherberg, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196151PMC
http://dx.doi.org/10.18632/oncotarget.2268DOI Listing
August 2014
64 Reads
10 Citations
6.360 Impact Factor

Targeting the HGF/MET pathway in gastric cancer.

Authors:
Florian Lordick

Lancet Oncol 2014 Aug 22;15(9):914-6. Epub 2014 Jun 22.

University Cancer Center Leipzig (UCCL), University Clinic Leipzig, D-04103 Leipzig, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70273-6DOI Listing
August 2014
14 Reads
8 Citations
24.690 Impact Factor

Mistletoe treatment for cancer--promising or passé?

Authors:
Florian Lordick

Dtsch Arztebl Int 2014 Jul;111(29-30):491-2

University Cancer Center Leipzig (UCCL), University of Leipzig.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2014.0493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150025PMC
July 2014
8 Reads
3.610 Impact Factor

Unmet needs and challenges in gastric cancer: the way forward.

Cancer Treat Rev 2014 Jul 13;40(6):692-700. Epub 2014 Mar 13.

Biomedical Research Institute IINCLIVA, University of Valencia, Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.03.002DOI Listing
July 2014
55 Reads
32 Citations
7.590 Impact Factor

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Gastric Cancer 2014 Apr 19;17(2):213-25. Epub 2013 Sep 19.

University Cancer Center Leipzig (UCCL), University Clinic Leipzig, University of Leipzig, Liebigstr. 20, 04301, Leipzig, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-013-0297-zDOI Listing
April 2014
48 Reads
23 Citations
3.720 Impact Factor

A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.

Ann Surg Oncol 2014 Mar 27;21(3):915-21. Epub 2013 Nov 27.

Institute of Pathology, University of Bern, Bern, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3410-yDOI Listing
March 2014
22 Reads
3 Citations
3.930 Impact Factor

(Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.

Dig Surg 2013 18;30(2):112-8. Epub 2013 Jul 18.

Department of Oncology/Hematology and Center of Palliative Care, Kliniken Essen-Mitte, DE-45136 Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350935DOI Listing
March 2014
31 Reads
1 Citation
1.742 Impact Factor

Connections are clearly more complexy.

Dtsch Arztebl Int 2013 Nov;110(44):753

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2013.0753aDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831243PMC
November 2013
27 Reads
3.610 Impact Factor

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

J Natl Cancer Inst 2013 Nov 9;105(21):1600-7. Epub 2013 Oct 9.

Affiliations of authors: Translational Research and Clinical Trial Center, Hokkaido University Hospital, Sapporo, Japan (KO); Biostatistics dpt, INSEM U900, Institut Curie, Paris, France (XP); Mayo Clinic, Rochester, MN (SA, DS); Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea (Y-JB); SWOG Statistical Center, Seattle, WA (JB); Brussels, Belgium (HB); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Department of Biostatistics, Harvard School of Public Health, Boston, MA (PC); University Clinic Leipzig, University Cancer Center, Leipzig, Germany (FL); Biostatistics and Epidemiology department, Institut Gustave-Roussy, Universite Paris XI, Villejuif, France (SMi, J-PP); Department of Biostatistics, Yokohama City University, Yokohama, Japan (SMo); Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan (YO); Gastro-enterology department, University Hospital Europeen Georges Pompidou, Paris, France (PR); Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan (MS); Tokai Central Hospital, Kakumuhara, Japan (JS); Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan (KS); Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium (EVC); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB, TB); I-BioStat, Hasselt University, Diepenbeek, Belgium (MB, TB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202244PMC
November 2013
41 Reads
18 Citations
12.583 Impact Factor

Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.

Diagn Mol Pathol 2013 Sep;22(3):127-37

Departments of Pathology, Christian-Albrechts-University, Kiel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PDM.0b013e318284188eDOI Listing
September 2013
46 Reads
15 Citations
2.275 Impact Factor

Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography.

Authors:
Florian Lordick

Recent Results Cancer Res 2012 ;196:201-11

University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-31629-6_14DOI Listing
April 2013
20 Reads

Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.

Langenbecks Arch Surg 2013 Feb 27;398(2):239-49. Epub 2012 Dec 27.

Department of Surgery, University Hospital of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00423-012-1039-0DOI Listing
February 2013
13 Reads
6 Citations
2.160 Impact Factor

Multimodal treatment of esophageal cancer.

Langenbecks Arch Surg 2013 Feb 13;398(2):177-87. Epub 2012 Sep 13.

University Cancer Center Leipzig (UCCL), University Clinic Leipzig, Liebigstraße 20, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00423-012-1001-1DOI Listing
February 2013
42 Reads
8 Citations
2.160 Impact Factor

Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.

Ann Surg Oncol 2012 Jul 7;19(7):2119-27. Epub 2012 Mar 7.

National Center of Tumor Diseases, University of Heidelberg, and Department of Surgery, University Hospital of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2F978-3-642-316
Web Search
http://link.springer.com/content/pdf/10.1245/s10434-012-2254
Web Search
http://www.springerlink.com/index/10.1245/s10434-012-2254-1
Publisher Site
http://dx.doi.org/10.1245/s10434-012-2254-1DOI Listing
July 2012
27 Reads
12 Citations
3.930 Impact Factor

Gastrointestinal cancer: Salvage chemotherapy in gastric cancer--more than a straw?

Authors:
Florian Lordick

Nat Rev Clin Oncol 2012 May 1;9(6):312-3. Epub 2012 May 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2012.76DOI Listing
May 2012
28 Reads
1 Citation
14.180 Impact Factor

Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients.

Langenbecks Arch Surg 2012 Jan 20;397(1):45-55. Epub 2011 May 20.

Surgical Department, University Hospital Heidelberg, INF 110, Heidelberg, 69120, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00423-011-0805-8
Publisher Site
http://dx.doi.org/10.1007/s00423-011-0805-8DOI Listing
January 2012
35 Reads
3 Citations
2.160 Impact Factor

The role of PET in predicting response to chemotherapy in oesophago-gastric cancer.

Authors:
Florian Lordick

Acta Gastroenterol Belg 2011 Dec;74(4):530-5

Department of Medicine, Klinikum Braunschweig, Hannover Medical School, Germany.

View Article

Download full-text PDF

Source
December 2011
6 Reads
1 Citation

Current standard and trends in oesophageal cancer.

Authors:
Florian Lordick

Eur J Cancer 2011 Sep;47 Suppl 3:S353-4

3rd Medical Department, Haematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(11)70200-3DOI Listing
September 2011
4 Reads
5.420 Impact Factor

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

J Nucl Med 2011 Aug 15;52(8):1189-96. Epub 2011 Jul 15.

3rd Department of Medicine (Haematology and Medical Oncology), Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.110.085803DOI Listing
August 2011
60 Reads
28 Citations
6.160 Impact Factor

Gastric cancer: surgery in 2011.

Langenbecks Arch Surg 2011 Aug 14;396(6):743-58. Epub 2011 Jan 14.

Department of Surgery, University of Heidelberg, INF 110, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00423-010-0738-7DOI Listing
August 2011
20 Reads
19 Citations
2.160 Impact Factor

How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?

Curr Opin Oncol 2011 Jul;23(4):396-402

National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3283469567DOI Listing
July 2011
129 Reads
9 Citations
4.470 Impact Factor

Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.

Onkologie 2010 20;33(10):512-8. Epub 2010 Sep 20.

TagesTherapieZentrum am Interdisziplinären Tumorzentrum Mannheim und III. Medizinische Klinik, Universitätsmedizin Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000319699DOI Listing
February 2011
26 Reads
1 Citation
0.840 Impact Factor

Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer.

Authors:
Florian Lordick

Future Oncol 2011 Feb;7(2):187-99

Department of Hematology & Medical Oncology, Klinikum Braunschweig, Celler Straße 38, Braunschweig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.178DOI Listing
February 2011
70 Reads
9 Citations
2.480 Impact Factor

High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients.

J Surg Oncol 2010 Oct;102(5):503-8

Institute of Pathology, Technische Universität München, Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21641DOI Listing
October 2010
10 Reads
5 Citations
3.244 Impact Factor

Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.

Langenbecks Arch Surg 2010 Apr 12;395(4):373-9. Epub 2009 Mar 12.

Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00423-009-0478-8DOI Listing
April 2010
19 Reads
3 Citations
2.160 Impact Factor

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas.

Mod Pathol 2009 Dec 2;22(12):1555-63. Epub 2009 Oct 2.

Institute of Pathology, Technische Universität München, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.123DOI Listing
December 2009
99 Reads
24 Citations
6.190 Impact Factor

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.

Eur J Cancer 2009 Dec 12;45(18):3326-35. Epub 2009 Oct 12.

Institute of Pathology, Technische Universität München, Trogerstr. 18, 81675 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.09.021DOI Listing
December 2009
148 Reads
5 Citations
5.420 Impact Factor

Accomplishments in 2008 in the adjuvant treatment of rectal cancer.

Gastrointest Cancer Res 2009 Sep;3(5 Supplement 2):S8-S14

Department of Radiation Oncology, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791392PMC
September 2009
6 Reads

Symptomatic hyponatraemia caused by cylophosphamide.

Onkologie 2009 May 3;32(5):280-2. Epub 2009 Apr 3.

Nationales Centrum fur Tumorerkrankungen, Universitatsklinikum Heidelberg, Im Neuenheimer Feld 350, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000209292DOI Listing
May 2009
59 Reads
2 Citations
0.840 Impact Factor

Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.

Ann Surg Oncol 2009 Apr 3;16(4):1017-25. Epub 2009 Feb 3.

Department of Surgery, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0336-5DOI Listing
April 2009
75 Reads
10 Citations
3.930 Impact Factor

Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.

Oncology (Williston Park) 2009 Feb;23(2 Suppl 1):18-25

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
February 2009
4 Reads
2 Citations
2.981 Impact Factor

[Treatment of gastric cancer].

Onkologie 2008 14;31 Suppl 5:32-9. Epub 2008 Nov 14.

Nationales Zentrum für Tumorerkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000163075DOI Listing
February 2009
11 Reads
1 Citation
0.840 Impact Factor

The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT.

Int J Colorectal Dis 2009 Feb 3;24(2):191-200. Epub 2008 Dec 3.

Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaningerstr. 22, 81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-008-0616-8DOI Listing
February 2009
44 Reads
13 Citations
2.450 Impact Factor

Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.

Onkologie 2009 Feb 19;32(1-2):50-3. Epub 2009 Jan 19.

Department of Medical Oncology, National Center for Tumor Diseases, Universität Heidelberg, Im Neuenheimer Feld 350, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000183750DOI Listing
February 2009
127 Reads
2 Citations
0.840 Impact Factor

Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.

Clin Cancer Res 2008 Dec;14(24):8279-87

Institute of Pathology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0679DOI Listing
December 2008
45 Reads
19 Citations
8.722 Impact Factor

Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma.

World J Surg 2008 Dec;32(12):2655-60

Department of Surgery, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaninger Strasse 22, 81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-008-9722-6DOI Listing
December 2008
42 Reads
2 Citations
2.642 Impact Factor

The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.

Gastrointest Cancer Res 2008 Nov;2(6):287-94

Department of Surgery, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632563PMC
November 2008
20 Reads
13 Citations

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.

Eur J Cancer 2008 Sep 17;44(13):1807-19. Epub 2008 Jul 17.

National Centre for Tumour Diseases, Department of Medical Oncology, University of Heidelberg, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.06.005DOI Listing
September 2008
77 Reads
9 Citations
5.420 Impact Factor

The evolving role of catumaxomab in gastric cancer.

Expert Opin Biol Ther 2008 Sep;8(9):1407-15

University of Heidelberg, National Center for Tumour Diseases, Department of Medical Oncology, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.8.9.1407DOI Listing
September 2008
29 Reads
3.743 Impact Factor

Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.

Int J Colorectal Dis 2008 Aug 29;23(8):773-82. Epub 2008 Apr 29.

Department of Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-008-0490-4DOI Listing
August 2008
58 Reads
11 Citations
2.450 Impact Factor

Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up.

Onkologie 2008 Jul 16;31(7):366-72. Epub 2008 Jun 16.

Department of Surgery, University of Schleswig-Holstein, Campus Lubeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000135515DOI Listing
July 2008
18 Reads
3 Citations
0.840 Impact Factor

Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.

Gastrointest Cancer Res 2008 Jul;2(4):187-97

National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632837PMC
July 2008
20 Reads
2 Citations

The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.

Gastric Cancer 2008 29;11(1):1-9. Epub 2008 Mar 29.

Department of Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-007-0448-1DOI Listing
June 2008
25 Reads
6 Citations
3.720 Impact Factor

[Which tumor patients profit from interdisciplinary psychoeducation in the framework of a tumor therapy?].

Z Psychosom Med Psychother 2007 ;53(4):324-38

Abteilung Psychosomatik und Psychotherapie der Medizinischen Hochschule Hannover.

View Article

Download full-text PDF

Source
March 2008
24 Reads
2 Citations

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.

Int J Radiat Oncol Biol Phys 2008 Mar 19;70(4):1081-6. Epub 2007 Sep 19.

Department of Radiation Therapy, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.07.2356DOI Listing
March 2008
55 Reads
21 Citations
4.260 Impact Factor

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

J Nucl Med 2008 Jan 12;49(1):22-9. Epub 2007 Dec 12.

Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.107.045864DOI Listing
January 2008
57 Reads
43 Citations
6.160 Impact Factor

Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.

Eur J Nucl Med Mol Imaging 2007 Dec 7;34(12):1925-32. Epub 2007 Aug 7.

Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstrasse 22, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-007-0521-3DOI Listing
December 2007
39 Reads
24 Citations
5.383 Impact Factor

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.

J Nucl Med 2007 Dec 15;48(12):1945-50. Epub 2007 Nov 15.

Department of Nuclear Medicine, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.107.044867DOI Listing
December 2007
26 Reads
24 Citations
6.160 Impact Factor

Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.

Ann Surg 2007 Oct;246(4):624-8; discussion 628-31

Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e318155a7d1DOI Listing
October 2007
41 Reads
7 Citations
8.330 Impact Factor

Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features.

Clin Cancer Res 2007 Sep;13(17):5095-102

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0241DOI Listing
September 2007
37 Reads
6 Citations
8.722 Impact Factor

PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

Eur J Nucl Med Mol Imaging 2007 Jun 29;34(6):878-83. Epub 2006 Dec 29.

Department of Nuclear Medicine, Technische Universität München, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-006-0292-2DOI Listing
June 2007
28 Reads
17 Citations
5.383 Impact Factor

Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.

Radiology 2007 Jun 26;243(3):744-51. Epub 2007 Apr 26.

Department of Radiology, Technische Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2433060421DOI Listing
June 2007
46 Reads
8 Citations
6.870 Impact Factor

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.

Eur J Cancer 2007 Jan 28;43(2):299-307. Epub 2006 Nov 28.

Third Medical Department, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.09.019DOI Listing
January 2007
30 Reads
9 Citations
5.420 Impact Factor

Current treatment approach to locally advanced esophageal cancer: is resection mandatory?

Future Oncol 2006 Dec;2(6):717-21

Department of Surgery & Medical Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.2.6.717DOI Listing
December 2006
21 Reads
2 Citations
2.480 Impact Factor

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

J Clin Oncol 2006 Oct 11;24(29):4692-8. Epub 2006 Sep 11.

Department of Surgery, Technische Universitaet Muenchen, Ismaningerstr 22, D-81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.7801DOI Listing
October 2006
21 Reads
77 Citations
18.430 Impact Factor

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.

Ann Thorac Surg 2006 Jul;82(1):293-7

Third Department of Medicine (Hematology/Oncology), Institute for Medical Statistics and Epidemiology, and Munich Center for Clinical Studies, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000349750600229
Publisher Site
http://dx.doi.org/10.1016/j.athoracsur.2006.01.097DOI Listing
July 2006
22 Reads
3.850 Impact Factor

Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy.

Radiology 2006 May 16;239(2):472-80. Epub 2006 Mar 16.

Department of Radiology, Technische Universitaet Muenchen, Klinikum rechts der Isar, Ismaninger Str 22, 81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2391050043DOI Listing
May 2006
36 Reads
15 Citations
6.870 Impact Factor

Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.

Int J Radiat Oncol Biol Phys 2006 Apr 28;64(5):1295-8. Epub 2006 Feb 28.

Third Department of Internal Medicine (Hematology/Medical Oncology), Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.12.004DOI Listing
April 2006
29 Reads
18 Citations
4.260 Impact Factor

Top co-authors

Katja Ott
Katja Ott

University of Heidelberg

37
Karen Becker
Karen Becker

Institute of Pathology

29
Rupert Langer
Rupert Langer

Institute of Pathology

16
Ken Herrmann
Ken Herrmann

University Hospital Würzburg

15
Markus Schwaiger
Markus Schwaiger

Technische Universität München

14
Sylvie Lorenzen
Sylvie Lorenzen

National Center of Tumor Diseases

10
Christian Peschel
Christian Peschel

Technische Universität München

9
Susanne Blank
Susanne Blank

University of Heidelberg

8